GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » Total Equity

Concord Medical Services Holdings (Concord Medical Services Holdings) Total Equity : $244.67 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings Total Equity?

Concord Medical Services Holdings's total equity for the quarter that ended in Dec. 2023 was $244.67 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Concord Medical Services Holdings Total Equity Historical Data

The historical data trend for Concord Medical Services Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Medical Services Holdings Total Equity Chart

Concord Medical Services Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 269.36 367.14 430.77 289.12 244.67

Concord Medical Services Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 430.77 369.92 289.12 291.56 244.67

Concord Medical Services Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Concord Medical Services Holdings's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=847.867-603.198
=244.67

Concord Medical Services Holdings's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=847.867-603.198
=244.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Services Holdings Total Equity Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Services Holdings (Concord Medical Services Holdings) Business Description

Traded in Other Exchanges
N/A
Address
Room 2701-05 , 36 North Third Ring Road, Tower A, Global Trade Center, Dongcheng District, Beijing, CHN, 100013
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.